CG
RARE icon

Cutler Group’s Ultragenyx Pharmaceutical RARE Stock Holding History

Cutler Group’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,010
Closed -$36K – 4202
2023
Q3 		$36K Buy
+1,010
New +$40K ﹤0.01% 1677
2021
Q1 		– Sell
-411
Closed -$56K – 6158
2020
Q4 		$56K Buy
+411
New +$48.8K ﹤0.01% 1932
2019
Q4 		– Sell
-200
Closed -$8K – 4484
2019
Q3 		$8K Sell
200
-300
-60% -$16.3K ﹤0.01% 2762
2019
Q2 		$31K Buy
+500
New +$31.8K ﹤0.01% 1892
2019
Q1 		– Sell
-1,821
Closed -$79K – 4619
2018
Q4 		$79K Sell
1,821
-179
-9% -$9.78K 0.01% 1193
2018
Q3 		$152K Sell
2,000
-150
-7% -$12.2K 0.01% 970
2018
Q2 		$165K Buy
2,150
+2,000
+1,333% +$129K 0.01% 872
2018
Q1 		$7K Sell
150
-100
-40% -$5.04K ﹤0.01% 3063
2017
Q4 		$11K Sell
250
-2,263
-90% -$111K ﹤0.01% 3061
2017
Q3 		$133K Buy
2,513
+785
+45% +$46.5K 0.01% 1442
2017
Q2 		$107K Buy
1,728
+1,713
+11,420% +$103K ﹤0.01% 1806
2017
Q1 		$1K Sell
15
-10,695
-100% -$815K ﹤0.01% 5951
2016
Q4 		$753K Buy
10,710
+6,575
+159% +$466K 0.03% 510
2016
Q3 		$293K Buy
+4,135
New +$264K 0.01% 925
2016
Q2 		– Sell
-298
Closed -$19.3K – 7165
2016
Q1 		$18K Buy
+298
New +$19.5K ﹤0.01% 3403

Other funds holding RARE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Cutler Group's RARE Position: Q4 2023 in Review

Cutler Group sold out of Ultragenyx Pharmaceutical (RARE) in Q4 2023, closing a stake of 1,010 shares — an estimated $36K sold.

Cutler Group first reported a position in RARE in Q1 2016 and held it in 15 quarters. The position peaked at $753K in Q4 2016. 236 funds tracked by Wall St. Rank hold RARE as of Q4 2023.

  • Cutler Group reported no remaining Ultragenyx Pharmaceutical position as of Q4 2023 after selling out during the quarter.
  • Cutler Group sold 1,010 Ultragenyx Pharmaceutical shares in Q4 2023, an estimated $36K.
  • Cutler Group first reported a position in Ultragenyx Pharmaceutical in Q1 2016 and held it in 15 quarters.
  • Cutler Group's Ultragenyx Pharmaceutical position peaked at $753K in Q4 2016.
  • 236 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q4 2023.

Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.